AJP - GI AJP: Advances in Physiology Education
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Am J Physiol Gastrointest Liver Physiol 261: G426-G432, 1991;
0193-1857/91 $5.00
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Gullikson, G. W.
Right arrow Articles by Erwin, W. D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Gullikson, G. W.
Right arrow Articles by Erwin, W. D.

AJP - Gastrointestinal and Liver Physiology, Vol 261, Issue 3 426-G432, Copyright © 1991 by American Physiological Society

ARTICLES

Alpha 2-adrenergic model of gastroparesis: validation with renzapride, a stimulator of motility

G. W. Gullikson, M. A. Virina, R. Loeffler and W. D. Erwin
Gastrointestinal Diseases Research Department, G.D. Searle and Co., Skokie, IL 60077.

Motility-stimulating drugs can increase gastric antral and intestinal contractions but do not usually enhance emptying unless gastroparesis is present. An alpha 2-adrenergic agonist (SC-39585A) was used to inhibit antroduodenal motility and simulate gastroparesis in dogs. SC-39585A caused dose-related inhibition of emptying of solid and liquid meals as well as the antral and duodenal motility responses to the solid meal. The motility-enhancing agent renzapride (100 micrograms/kg iv) did not enhance emptying of the solid meal under nondelayed conditions. However, at the same dose it partially reversed the delay in solid emptying but only when antroduodenal motility was incompletely (30 micrograms/kg sc) and not totally (100 micrograms/kg sc) inhibited by SC-39585A. This was done in part by antagonizing antral but not duodenal inhibition of motility. Renzapride was also effective orally in reversing the delay in solid emptying. Similarly, renzapride reversed the delay in liquid emptying caused by SC-39585A (30 micrograms/kg sc). An alpha 2-adrenergic agonist can be used to model gastroparesis in dogs by inhibiting antroduodenal motility and can also be used to examine the actions of motor stimulants, such as renzapride, which promote gastric emptying.


This article has been cited by other articles:


Home page
 Am. J. Physiol. Gastrointest. Liver Physiol.Home page
B. E. Viramontes, A. Malcolm, M. Camilleri, L. A. Szarka, S. McKinzie, D. D. Burton, and A. R. Zinsmeister
Effects of an alpha 2-adrenergic agonist on gastrointestinal transit, colonic motility, and sensation in humans
Am J Physiol Gastrointest Liver Physiol, December 1, 2001; 281(6): G1468 - G1476.
[Abstract] [Full Text] [PDF]

Home page
 J. Pharmacol. Exp. Ther.Home page
O. Yamamoto, H. Niida, K. Tajima, Y. Shirouchi, Y. Kyotani, F. Ueda, M. Kise, and K. Kimura
Effect of YNS-15P, a New Alpha-2 Adrenoceptor Antagonist, on Stress-Stimulated Colonic Propulsion in Rats
J. Pharmacol. Exp. Ther., November 1, 1998; 287(2): 691 - 696.
[Abstract] [Full Text]

Home page
 J. Pharmacol. Exp. Ther.Home page
T. Tanaka, A. Mizumoto, E. Mochiki, H. Suzuki, Z. Itoh, and S. Omura
Effects of EM574 and Cisapride on Gastric Contractile and Emptying Activity in Normal and Drug-Induced Gastroparesis in Dogs
J. Pharmacol. Exp. Ther., November 1, 1998; 287(2): 712 - 719.
[Abstract] [Full Text]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online